EFFECT OF ORAL CALCIUM ON NONINVASIVE INDEXES OF BONE-FORMATION AND BONE MASS IN HEMODIALYSIS-PATIENTS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
M. Rudnicki et al., EFFECT OF ORAL CALCIUM ON NONINVASIVE INDEXES OF BONE-FORMATION AND BONE MASS IN HEMODIALYSIS-PATIENTS - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY, Mineral and electrolyte metabolism, 20(3), 1994, pp. 130-134
The purpose of this study was to evaluate the effect of high-dose oral
calcium on biochemical indices of bone formation, bone bisphosphonate
clearance (BBC) and bone mineral content (BMC) of the distal forearm
in patients undergoing hemodialysis. Eighteen patients agreed to parti
cipate and were randomized in a double-blind manner to receive either
2 g elemental calcium/day (n = 9) or placebo (n = 9) for 6 months. Pre
vious treatment with aluminum-containing phosphate binders was continu
ed unchanged throughout the study. In the placebo group, serum alkalin
e phosphatase and osteocalcin tended to increase by 8.0 and 10.2%, res
pectively, while BBC changed significantly by 49.5% (p < 0.05). In the
calcium group the opposite was observed with small decreases in alakl
ine phosphatase and osteocalcin by 8.2 and 11.0%, respectively, and no
change in BBC. BMC decreased by 5.0% in the placebo group, but increa
sed by 5.2% in the calcium group, resulting in a difference of 10.2% (
p < 0.05). The present study demonstrates that high-dose oral calcium
tends to reduce bone turnover and seems able to prevent bone loss in h
emodialyzed patients.